Ads
related to: life after hodgkin's lymphoma treatment guidelines protocol success- What to Expect
Learn More About What to Expect
From a Hodgkin Lymphoma Treatment.
- Support & Resources
Explore Support & Resource Info
on a Hodgkin's Treatment Option.
- Study Results
Visit the Site to Access Clinical
Study Results & Side Effects Info.
- Pediatric Treatment
Learn More About a Hodgkin Lymphoma
Treatment Option for Your Child.
- What to Expect
careinfo.mayoclinic.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
As of 2007, ABVD is widely used as the initial chemotherapy treatment for newly diagnosed Hodgkin lymphoma. [citation needed] It has been the most effective and least toxic chemotherapy regimen available for treating early-stage Hodgkin Lymphoma. [1]
MOPP is a combination chemotherapy regimen used to treat Hodgkin lymphoma. The acronym is derived from the component drugs of the regimen: ustargen (also known as mechlorethamine, chlormethine, mustine, nitrogen mustard, or MSD) ncovin (also known as Vincristine or VCR) rocarbazine (also known as Matulane or Natulan)
Stanford V (usually spoken as Stanford Five), is a chemotherapy regimen (with accompanying Radiation therapy) intended as a first-line treatment for Hodgkin lymphoma.The regimen was developed in 1988, with the objective of maintaining a high remission rate while reducing the incidence of acute and long term toxicity, pulmonary damage, and sterility observed in alternative treatment regimens ...
An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.
GVD is a chemotherapy regimen, used for salvage treatment of relapsed or refractory Hodgkin disease, including those patients who relapse after stem cell transplantation. [1] The GVD regimen consists of three drugs, from which its name is derived: Gemcitabine; Vinorelbine; and; Doxil, a pegylated liposomal formulation of doxorubicin.
BEACOPP is a chemotherapy regimen for treatment of Hodgkin lymphoma developed by the German Hodgkin Study Group [1] used for patients in Stages > II or early (IA or IB) with unfavorable risk factors. [2] Patients typically receive treatment in cycles of 21 days with no drugs given on days 15–21. [3]
Ads
related to: life after hodgkin's lymphoma treatment guidelines protocol success